You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 4, April 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (15)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Cerebrovascular Disease
 •Dementias
 •Stroke
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Poststroke Dementia

Influence of Hippocampal Atrophy

Marie-Anne Cordoliani-Mackowiak, MD; Hilde Hénon, MD, PhD; Jean-Pierre Pruvo, MD; Florence Pasquier, MD, PhD; Didier Leys, MD

Arch Neurol. 2003;60:585-590.

Background  The prevalence of dementia is increased after stroke. Medial temporal lobe atrophy (MTLA) is associated with Alzheimer disease, and with prestroke dementia in patients who have had a stroke.

Objective  To determine the influence of MTLA on the long-term risk of dementia after stroke, after excluding the patients who had prestroke dementia.

Methods  The study was conducted in 144 consecutive patients who had a stroke, who were aged 40 years or older (66 women and 78 men; median age, 72 years), and who had an Informant Questionnaire on Cognitive Decline in the Elderly score lower than 104. On admission to the hospital all patients underwent a noncontrast computed tomographic scan including temporal lobe–positioned slices. A cut-off of 11.5 mm was used to differentiate patients with MTLA from those without MTLA. Patients were followed up with clinical and cognitive assessments over a 3-year period.

Results  Three years after stroke, 34 patients (23.6%) had developed new-onset dementia. The cumulative proportion of survivors without dementia was 57.6% in patients with MTLA and 80.8% in patients without MTLA (P = .02). The unadjusted relative risk of poststroke dementia associated with MTLA was 2.3 (95% confidence interval, 1.1-4.7). However, using the Cox proportional hazards model, MTLA did not seem to be an independent predictor of poststroke dementia. Independent predictors of poststroke dementia were increasing age, diabetes mellitus, severity of the clinical deficit at admission, and severity of leukoaraiosis on computed tomography.

Conclusions  Patients who had a stroke and MTLA more frequently develop dementia than patients without MTLA, but our study does not suggest that MTLA independently contributes to dementia. A longer follow-up may be necessary to reevaluate the influence of MTLA.


From the Department of Neurology, Stroke Unit (Drs Cordoliani-Mackowiak, Hénon, and Leys) and Memory Clinic (Drs Hénon and Pasquier), and the Department of Neuroradiology (Dr Pruvo), University of Lille, Lille, France.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Influence of cognitive impairment on the institutionalisation rate 3 years after a stroke
Pasquini et al.
J. Neurol. Neurosurg. Psychiatry 2007;78:56-59.
ABSTRACT | FULL TEXT  

The Cingulate as a Catalyst Region for Global Dysfunction: a Dynamical Modelling Paradigm
Kronhaus and Willshaw
Cereb Cortex 2006;16:1212-1224.
ABSTRACT | FULL TEXT  

White Matter Lesions Are Prevalent but Differentially Related With Cognition in Aging and Early Alzheimer Disease
Burns et al.
Arch Neurol 2005;62:1870-1876.
ABSTRACT | FULL TEXT  

Evolution of Cognitive Impairment After Stroke and Risk Factors for Delayed Progression
del Ser et al.
Stroke 2005;36:2670-2675.
ABSTRACT | FULL TEXT  

The Amyloid-{beta} Peptide Suppresses Transforming Growth Factor-{beta}1-induced Matrix Metalloproteinase-2 Production via Smad7 Expression in Human Monocytic THP-1 Cells
Lee et al.
J. Biol. Chem. 2005;280:7845-7853.
ABSTRACT | FULL TEXT  

NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia
Ballard et al.
Neurology 2004;63:983-988.
ABSTRACT | FULL TEXT  

Delayed poststroke dementia: A 4-year follow-up study
Altieri et al.
Neurology 2004;62:2193-2197.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.